claim
Senolytics, which remove senescent cells, and senomorphics, which attenuate the senescence-associated secretory phenotype (SASP), can ameliorate diabetes and its complications by alleviating insulin resistance and reducing tissue inflammation.

Authors

Sources

Referenced by nodes (3)